Cellectar Biosciences Inc
(CLRB)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -11,479 | -7,570 | -3,958 | -14,093 | -10,713 |
| Depreciation Amortization | 106 | 70 | 34 | 133 | 100 |
| Other Working Capital | 908 | 669 | 252 | 1,386 | 943 |
| Other Operating Activity | 402 | 269 | 160 | 880 | 658 |
| Operating Cash Flow | $-10,064 | $-6,562 | $-3,512 | $-11,694 | $-9,013 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -45 | -45 | -11 | -25 | -19 |
| Investing Cash Flow | $-45 | $-45 | $-11 | $-25 | $-19 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 184 | 184 | N/A | N/A | 0 |
| Debt Repayment | N/A | N/A | N/A | -2 | -2 |
| Common Stock Issued | 18,290 | 18,259 | N/A | 9,025 | 9,025 |
| Other Financing Activity | -138 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $18,336 | $18,443 | $0 | $9,022 | $9,022 |
| Beginning Cash Position | 10,615 | 10,615 | 10,615 | 13,311 | 13,311 |
| End Cash Position | 18,842 | 22,450 | 7,092 | 10,615 | 13,302 |
| Net Cash Flow | $8,227 | $11,836 | $-3,523 | $-2,696 | $-9 |
| Free Cash Flow | |||||
| Operating Cash Flow | -10,064 | -6,562 | -3,512 | -11,694 | -9,013 |
| Capital Expenditure | -45 | -45 | -11 | -25 | -19 |
| Free Cash Flow | -10,109 | -6,607 | -3,523 | -11,718 | -9,031 |